Pingkui Enema Alleviates TNBS-Induced Ulcerative Colitis by Regulation of Inflammatory Factors, Gut Bifidobacterium, and Intestinal Mucosal Barrier in Rats

<div>Serum levels of IL-8, TNF-<i>α</i>, and IL-13 in rats: (a) concentration of IL-8 in serum of rats in each group (<i>n</i> = 7–10); (b) concentration of TNF-<i>α</i> in serum of rats in each group (<i>n</i> = 7–10); (c) concentration of IL-13 in serum of rats in each group (<i>n</i> = 7–10). Control indicates the control group, UC indicates the UC group, UC plus low dose indicates UC plus low dose of Pingkui enema, UC plus medium dose indicates UC plus medium dose of Pingkui enema, UC plus high dose indicates UC plus high dose of Pingkui enema, and UC plus sulfasalazine indicates UC plus sulfasalazine enteric-coated tablets.</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: Pingkui Enema Alleviates TNBS-Induced Ulcerative Colitis by Regulation of Inflammatory Factors, Gut Bifidobacterium, and Intestinal Mucosal Barrier in Rats 

Figure 4 | Pingkui Enema Alleviates TNBS-Induced Ulcerative Colitis by Regulation of Inflammatory Factors, Gut Bifidobacterium, and Intestinal Mucosal Barrier in Rats 